Navigation Links
Optimizing cell therapy against tumors is a balancing ACT

Adoptive cell transfer (ACT) therapy is used to treat patients with metastatic solid tumors. ACT involves the removal of some of the patient's cancer cells, and some of their immune T cells. When the cells are mixed together, specific parts of the cancer cells that stimulate the T cells to cause an immune attack can be identified. The T cells get expanded and re-infused into the patient to mount an immunological, anti-cancer response against the tumors. One of the challenges faced is selecting the appropriate T cells with proper antigen specificity.

In a new study appearing in the June 1 print issue of The Journal of Clinical Investigation, Nicholas Restifo and colleagues identified which cells are optimal for treating large, vascularized, established tumors. The authors use a mouse model that mimics the human clinical situation. They find that phenotypic and functional qualities of T cells are associated with the ability of ACT to cause regression of large, established melanomas. Seemingly paradoxical, naïve and early effector T cells are more effective for tumor treatment than more differentiated T cells.

In an accompanying commentary, Daniel Speiser and Pedro Romero write, "optimal therapeutic efficacy may depend on different T cell selection and preparation strategies" and these findings indicate that a pragmatic strategy for ACT is to keep the in vitro T cell expansion phase as short as possible to keep them naïve. These findings are important for development of improved adoptive immunotherapy approaches for treating tumors and established infectious diseases.

TITLE: Acquisition of full effector function in vitro paradoxically impairs the in vivo anti-tumor efficacy of adoptively transferred CD8+ T cells

TITLE: Towards improved immunocompetence of adoptively transferred CD8+ T cells


'"/>

Source:Journal of Clinical Investigation


Page: 1

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2018)... , ... August 23, 2018 , ... ... has for increased sensitivity and specificity over more commonly used analytical techniques. However, ... the added burden of development and validation of methods that must be undertaken ...
(Date:8/26/2018)... ... August 25, 2018 , ... Maire Mayne, an ... energy treated nutraceutical to reduce inflammation and autoimmune disorders and improve overall immune ... well as inflammation. The following data was reported:,     Over ...
(Date:8/23/2018)... ... August 21, 2018 , ... CRISPR-Cas9 gene editing strategies ... species for the robust functional interrogation of complex biological processes. Gene editing in ... immunotherapies, the study of the autoimmunity, the understanding of host-pathogen dynamics that drive ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... ... 2018 , ... Franz Inc. , an early innovator in Artificial Intelligence ... Graphs, and Semantic Web Company , developers of the PoolParty Semantic Suite ... the Noam Chomsky Knowledge Graph. This project is the first aimed at ...
(Date:9/7/2018)... ... 06, 2018 , ... The Discovery on Target (DOT) conference ... industry’s preeminent event on novel drug targets.” BellBrook Labs’ high throughput screening (HTS) ... emerging targets in a quest to find new treatments for disease. , BellBrook ...
(Date:8/31/2018)... , ... August 29, 2018 , ... ... at both the University of Southampton and the Institute of Industrial Science, the ... at sea can dramatically accelerate the exploration and study of hard to reach ...
(Date:8/29/2018)... (PRWEB) , ... August 28, 2018 , ... ... be presenting the results of a safety study performed on an allogeneic (donor ... American Veterinary Regenerative Medicine Association (NAVRMA) conference in September. He is also ...
Breaking Biology Technology: